high fluorescent intermediate II

higly fluorescent intermediate of bacterial luciferase formed by the reaction of FMNH2 & O2 with bacterial luciferase; consists of luciferase & peroxyflavin

Also Known As:

Networked: 6 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Muyembe, Jean-Jacques: 1 article (01/2015)
2.	Gillet, Philippe: 1 article (01/2015)
3.	Mukadi, Pierre: 1 article (01/2015)
4.	Jacobs, Jan: 1 article (01/2015)
5.	Barbé, Barbara: 1 article (01/2015)
6.	Likwela, Joris: 1 article (01/2015)
7.	Luamba, Jean: 1 article (01/2015)
8.	Mumba, Dieudonné: 1 article (01/2015)
9.	Lukuka, Albert: 1 article (01/2015)
10.	Lutumba, Pascal: 1 article (01/2015)

Related Diseases

1.	Heart Failure 03/01/2014 - "Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial."
2.	Coronary Artery Disease (Coronary Atherosclerosis) 11/01/2007 - "These include: (i) post hoc subgroup analyses of prospective randomized clinical trials of statin therapy among patients with stable coronary artery disease where statins reduce the incidence of new HF; (ii) subgroup analysis of the evidence of statin use in large HF trails with different medication and medical devices; (iii) retrospective observational studies of statin use in HF; and (iv) prospective randomized clinical trials of statins in non-ischemic. "
3.	Myocardial Infarction 06/01/1999 - "Therefore, we analysed the data with respect to 4 different groups: (i) asymptomatic left ventricular systolic dysfunction (LVSD)--an early stage leading to chronic HF; (ii) chronic HF; and post-myocardial infarction (MI) LVSD differentiated into (iii) post-MI asymptomatic LVSD and (iv) post-MI chronic HF. "
4.	Malaria 01/01/2015 - "Main findings of the questionnaire were (i) use of other RDT products than recommended by the national malaria control programme (nearly 20% of participating HF), (ii) lack of training for a third (33.6%) of HF, (iii) high proportions (two-thirds, 66.5%) of HF reporting stock-outs. "
5.	Infection 09/01/2012 - "Sub-acute infection could be predicted in patients without clinical or paraclinical (white blood cell count and C-reactive protein) signs of infection in the acute period at (i) day: increased HFnorm, reduced LFnorm and LF/HF; (ii) night: reduced LF and VLF (P < 0.05). "

Related Drugs and Biologics

1.	Furosemide (Lasix)
2.	Dopamine (Intropin)
3.	C-Reactive Protein